Navigation Links
BioLineRx Reports Second Quarter 2013 Results
Date:8/6/2013

JERUSALEM, Aug. 6, 2013 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended June 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769)

Recent Highlights:

  • BL-1040 (ventricular remodeling) – The PRESERVATION I clinical trial, a CE-Mark registration trial, is proceeding as scheduled – there are currently 36 active sites in 9 countries, including 7 leading sites in the U.S. 
  • BL-5010 (skin lesions) – The necessary regulatory submissions to commence a pivotal, CE-Mark registration trial in Europe have been filed; the CRO and three sites in Germany have been selected. 
  • BL-8040 (AML) – The ongoing Phase 2 clinical trial is progressing as planned, and currently has 6 active sites recruiting (out of 8 sites in total); the first patient was enrolled in the study at the MD Anderson Cancer Center in Houston; Northwestern Memorial Hospital in Chicago was recently initiated into the trial and is expected to commence recruitment in the coming weeks; enrollment has been initiated at several leading sites in Israel following approval from the Israeli Ministry of Health;
  • BL-7010 (celiac disease) - Advanced GLP toxicology studies have begun and the CRO and sites in Europe have been selected for the upcoming Phase 1/2 clinical trial, expected to commence in Q4 2013; results of pre-clinical studies were presented and received with enthusiasm at two leading international meetings - the U.S. Celiac Disease Foundation's annual conference and the Digestive Disease Week conference.
  • Commenting on the ongoing progress within the Company's pipeline, Kinneret Savitsky, Ph.D., Chief Executive Officer of BioLineRx, remarked, "The second quarte
    '/>"/>

    SOURCE BioLineRx Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
    2. Regeneron Reports Second Quarter 2013 Financial and Operating Results
    3. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
    4. Volcano Reports Second Quarter Results; Medical Segment Revenues Increase More Than 13 Percent On A Constant Currency Basis
    5. Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
    6. PDI Reports 2013 Second Quarter Financial Results
    7. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
    8. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    9. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
    10. Neuland Labs Reports First Quarter Fiscal Year 2014 Financial Results
    11. IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... WAYNE, Pa. , July 1, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced that Bob Radie , president and ... upcoming conferences this summer. He will provide an ... (ketorolac tromethamine) Nasal Spray, approved product ...
    (Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE ... announced underwritten public offering of 3,636,364 shares of its ... $2.75 per share. BioPharmX has granted the underwriters a ... of common stock at the public offering price. ... Fund, an existing stockholder, has agreed to purchase 1,081,081 ...
    (Date:7/1/2015)... July 1, 2015 The global ... to reach USD 49,119.2 million by 2020, according to ... services is expected to remain the dominant and fastest ... million in 2012, and an estimated CAGR of 49.7% ... http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse full research report ...
    Breaking Medicine Technology:Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
    (Date:7/1/2015)... ... 01, 2015 , ... Dr. Jian-Dong Li, a professor and ... Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, ... The grant from the National Institute on Deafness and Other Communication Disorders of ...
    (Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced that they will welcome four new members to their industry leading ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Dr. Surya Challa of ... 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive CoolSculpting . On ... exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to literally freeze stubborn, ...
    (Date:7/1/2015)... ... July 01, 2015 , ... During the ... (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales Trainer) participated ... Phoenix, AZ. LTEN brings together learning and development professionals from more than 300 ...
    (Date:7/1/2015)... ... ... Convoy of Hope will partner with local businesses, churches, government ... 1, at Spring Lake Park High School. , During the celebration, Convoy of Hope ... goods and services including free food, health services, family portraits, job services, a carnival ...
    Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2
    ... Skin Cancer, at LPGA,s Samsung World Championship Where Sun Safety ... ... Oct. 17 Volunteer,dermatologists, nurses, medical students and others representing the,Women,s Dermatologic ... Moon Bay, CA to combat skin cancer at a time,when melanoma rates ...
    ... ADA and Crest/Oral-B Survey Unveiled ... 17, 2008 The American Dental,Association (ADA(R)), in collaboration with Crest(R) ... oral,health care., Here is a sneak peek at the ... care of one,s mouth, teeth and gums ...
    ... more than 5,500 benefit plans found 68.3 percent of organizations nationally use ... portion of the premium. , ... Kansas City, KS (PRWEB) October 17, ... reduction measures to combat rising health care costs. The Benefits USA ...
    ... genetic test to identify those most at risk from hair loss is ... ... UK (PRWEB) October 17, 2008 -- A groundbreaking genetic test to identify ... UK for both men and women. , , ,Currently only available at ...
    ... Year 2020, Food Companies Will Be Expected to Cede ... Oct. 16 Today,s consumers want to have a,greater ... the year,2020, consumers around the globe expect the way ... to a recent study of consumers in five,countries., ...
    ... Health Website Helps Reach Health-Conscious Consumers, FALLS ... 70 million,Americans experience some sort of digestive health ... Americans haven,t "digested" the ways in,which prebiotics and ... is helping to raise awareness for prebiotics and,probiotics ...
    Cached Medicine News:Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 2Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 3Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 4Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 2Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 3Health News:Employers' Methods for Containing and Reducing Costs Vary By Region 2Health News:Employers' Methods for Containing and Reducing Costs Vary By Region 3Health News:Breakthrough Baldness Genetic Test 2Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 2Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 3Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 4Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 5Health News:MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 2
    ... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
    ... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
    ... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
    ... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
    Medicine Products: